Intelligence · Clinical Pipeline

Anaxis Pharma Pipeline

All ClinicalTrials.gov programs at Anaxis Pharma — phase, modality, and trial IDs.

Programs
642

Quick answer

Anaxis Pharma has 642 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants

    Lacuna Pharma Pty Ltd

    Clostridioides difficile (C. difficile)

    phase 1 other active

    1 trial
  2. AGAMREE 40 mg/ml oral suspension

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial
  3. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial
  4. BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections with Wheezing Lower Respiratory Illness

    approved small molecule active

    1 trial
  5. Berotralstat, Berotralstat, Berotralstat, BEROTRALSTAT, Berotralstat

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema

    approved small molecule active

    1 trial
  6. Deltius 50.000 UI cápsulas duras. Colecalciferol (Vitamina D3), CALCIFEDIOL

    Lacuna Pharma Pty Ltd

    Severe vitamin D deficiency

    approved small molecule active

    1 trial
  7. Epidyolex 100 mg/ml oral solution

    Lacuna Pharma Pty Ltd

    Tuberous Scerlosis Complex

    approved small molecule active

    1 trial
  8. Feraccru 30 mg hard capsules

    Lacuna Pharma Pty Ltd

    iron deficient

    approved small molecule active

    1 trial
  9. LacTEST 0,45 g polvo para solución oral.

    Lacuna Pharma Pty Ltd

    Lactose intolerance

    approved small molecule active

    1 trial
  10. Livmarli 9.5 mg/mL oral solution

    Lacuna Pharma Pty Ltd

    Progressive Familial Intrahepatic Cholestasis, Alagille syndrome

    approved small molecule active

    1 trial
  11. MAXIGRA, 100 mg, tabletki powlekane

    Lacuna Pharma Pty Ltd

    Erectile dysfunction

    approved small molecule active

    1 trial
  12. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial
  13. Pariglasgene brecaparvovec

    Lacuna Pharma Pty Ltd

    Glycogen storage disease type Ia (GSDIa)

    approved small molecule active

    1 trial
  14. Tantum Verde P 3 mg pastiglie gusto menta

    Lacuna Pharma Pty Ltd

    NON STREPTOCOCCAL PHARYNGOTONSILLITIS

    approved small molecule active

    1 trial
  15. The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial
  16. Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Adipositas

    approved small molecule active

    1 trial
  17. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  18. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Anaxis Pharma have?

642 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs